feeds.serp.co
pitonne.jp /blog RSS Feed

G6PD Testing Before a 50 g Vitamin C IV: Hemolysis Risk

Aug 27, 2026Original

People considering high-dose vitamin C IV therapy often ask, “Do I need a G6PD test first?”

G6PD testing is a blood test that measures the activity of an enzyme involved in red blood cell function. When a high dose of vitamin C is administered intravenously, people with low G6PD activity may face a risk of hemolysis, a condition in which red blood cells break down.

At Pitonne, a G6PD test is required before receiving a 50 g high-dose vitamin C IV.

This article explains what G6PD testing means, why hemolysis is an important safety consideration, and what other health information should be reviewed before high-dose vitamin C IV therapy.

What Is G6PD?

G6PD stands for glucose-6-phosphate dehydrogenase. This enzyme helps protect red blood cells from oxidative stress.

Low G6PD activity is known as G6PD deficiency or reduced G6PD activity. It can be an inherited condition, and some people may not know that they have it.

G6PD status cannot be determined accurately through a general health questionnaire alone. When appropriate, a blood test is used, and the results are reviewed by a physician.

Why Is Hemolysis a Concern With High-Dose Vitamin C IV Therapy?

High-dose vitamin C IV therapy delivers a larger amount of vitamin C directly into the bloodstream than would normally be obtained through food or standard oral supplements.

In people with G6PD deficiency or reduced G6PD activity, high-dose intravenous vitamin C may increase the risk of hemolysis. Hemolysis occurs when red blood cells break down. If significant, it may contribute to hemolytic anemia.

For this reason, high-dose vitamin C IV therapy should not be considered without reviewing the patient’s G6PD status when testing is indicated. The National Cancer Institute also identifies G6PD deficiency as an important safety consideration for high-dose intravenous vitamin C.

NCI: Intravenous Vitamin C

Pitonne Requires G6PD Testing Before a 50 g IV

Pitonne offers high-dose vitamin C IV therapy in 25 g and 50 g doses.

Before receiving the 50 g high-dose vitamin C IV, a G6PD test is required.

The test helps the physician assess whether high-dose vitamin C IV therapy can be considered safely. The final decision is based not only on the G6PD result but also on kidney function, medical history, current medications, previous test results, and the patient’s condition on the day of treatment.

If the test indicates a concern, the 50 g high-dose vitamin C IV may not be appropriate. The physician will determine whether the treatment can be provided and whether another dose or option should be considered.

Is Testing Also Required for a 25 g Vitamin C IV?

The need for G6PD testing can vary depending on the dose, the individual’s health status, and the standards of the medical provider.

At Pitonne, G6PD testing is required before a 50 g high-dose vitamin C IV. For a 25 g dose, testing may also be considered depending on the patient’s medical history and overall condition.

Patients should not assume that testing is unnecessary simply because they are not receiving 50 g. The appropriate testing plan should be confirmed with a physician based on the intended dose and the patient’s health information.

Other Information That Should Be Reviewed

Kidney Function and History of Kidney Stones

Patients with reduced kidney function, a history of kidney stones, or who receive dialysis should disclose this information before treatment.

Reports involving high-dose intravenous vitamin C have included kidney-related concerns in people with pre-existing kidney problems. Depending on the individual situation, kidney function and treatment history may need to be reviewed carefully.

NCI: Intravenous Vitamin C

Heart Health and Fluid Balance

An IV infusion introduces fluid directly into the bloodstream. For people with certain heart or kidney conditions, fluid volume and infusion speed may require additional consideration.

Patients with a history of heart failure, swelling, shortness of breath, or kidney disease should inform the physician before receiving IV therapy.

Prescription Medications and Supplements

Patients should disclose all prescription medications, over-the-counter medicines, and supplements they are taking.

Depending on the medication and the condition being treated, the IV formulation or dose may need to be adjusted. In some situations, treatment may be postponed or not recommended.

Pregnancy and Breastfeeding

Patients who are pregnant, may be pregnant, or are breastfeeding should inform the medical team before treatment.

The ingredients and dose may require a different assessment during pregnancy or breastfeeding.

Information to Prepare Before a Consultation

Before discussing high-dose vitamin C IV therapy, it may be helpful to prepare information about:

Current symptoms, previous medical conditions, kidney or heart disease, history of kidney stones, prescription medications, supplements, allergies, pregnancy or breastfeeding status, previous blood test results, and the intended vitamin C dose.

If you have previously received a G6PD test or other blood tests at another medical facility, ask whether you can provide those results.

Previous results may sometimes be useful, but repeat testing may be considered depending on when the test was performed, the testing method, the result, and the dose being considered.

Symptoms to Watch for After an IV

If you experience a significant change in your condition after an IV, do not continue to monitor it on your own without contacting a medical professional.

Seek medical advice promptly if you experience difficulty breathing, chest pain, severe dizziness, sudden weakness, unusually dark urine, yellowing of the skin or whites of the eyes, a rash, swelling of the face or lips, or severe pain or swelling at the injection site.

If symptoms are severe or worsen rapidly, emergency medical care may be more appropriate than simply contacting the facility where the IV was provided.

Intravenous vitamin C may also affect certain blood glucose measurements and laboratory tests. If you need blood testing or glucose monitoring after receiving vitamin C IV therapy, tell the healthcare professional that you recently received an IV.

DailyMed: Ascorbic Acid Injection

Frequently Asked Questions

Is G6PD testing required before a 50 g high-dose vitamin C IV?

Yes. At Pitonne, G6PD testing is required before receiving a 50 g high-dose vitamin C IV. People with low G6PD activity may face a risk of hemolysis, in which red blood cells break down. A physician reviews the test result and other health information before making a decision.

What does a G6PD test show?

A G6PD test measures the activity of the G6PD enzyme, which is related to red blood cell function. The result is reviewed together with the planned dose, kidney function, medical history, medications, and current condition.

Can someone with G6PD deficiency receive high-dose vitamin C IV therapy?

High-dose vitamin C IV therapy may not be appropriate for people with G6PD deficiency or significantly reduced G6PD activity. In particular, Pitonne will not proceed with a 50 g infusion when safety cannot be confirmed. The final decision is made by a physician after reviewing the test result and the individual’s health status.

Can someone with kidney disease receive high-dose vitamin C IV therapy?

People with reduced kidney function, a history of kidney stones, or dialysis should be assessed before treatment. Whether IV therapy can be provided depends on kidney function, the planned dose, current treatment, and the physician’s clinical judgment.

Summary

G6PD status is an important safety consideration when high-dose vitamin C is administered intravenously.

People with G6PD deficiency or reduced G6PD activity may face a risk of hemolysis when exposed to high doses of vitamin C. For this reason, Pitonne requires a G6PD test before providing a 50 g high-dose vitamin C IV.

Safety assessment may also include kidney function, heart and kidney history, current medications, supplements, pregnancy or breastfeeding status, and the patient’s condition on the day of treatment.

If you are considering high-dose vitamin C IV therapy in Tokyo, discuss the intended dose and your current health information with a physician, including whether G6PD testing is appropriate.

Related Reading

Are Blood Tests Needed Before Regular IV Therapy?

Pitonne High-Dose Vitamin C IV Therapy

Nutrition Blood Testing

References

NCI: Intravenous Vitamin C

DailyMed: Ascorbic Acid Injection

Related Pitonne Services

Contact Pitonne

Contact Pitonne to discuss clinician-guided wellness options and whether a service is appropriate for your goals.

Contact Us